Ticker | $ Bought |
---|---|
vaxcyte inc | 34,281,000 |
celldex therapeutics inc new | 30,591,000 |
galapagos nv | 23,032,000 |
cogent biosciences inc | 21,600,000 |
cytokinetics inc | 21,120,000 |
bicara therapeutics inc | 20,376,000 |
travere therapeutics inc | 15,389,000 |
beam therapeutics inc | 12,250,000 |
Ticker | % Inc. |
---|---|
ionis pharmaceuticals inc | 25.00 |
Ticker | % Reduced |
---|---|
skye bioscience inc | -96.16 |
silence therapeutics plc | -93.23 |
neumora therapeutics inc. | -83.33 |
spyre therapeutics inc | -82.61 |
nuvalent inc | -80.77 |
vera therapeutics inc | -73.68 |
dyne therapeutics inc | -69.81 |
atyr pharma inc | -66.67 |
Ticker | $ Sold |
---|---|
cybin inc | -21,680,000 |
elevation oncology inc | -20,790,000 |
xencor inc | -56,790,000 |
relay therapeutics inc | -16,952,000 |
stoke therapeutics inc | -28,371,000 |
moonlake immunotherapeutics | -65,955,000 |
applied therapeutics inc | -5,323,800 |
xenon pharmaceuticals inc | -29,242,500 |
Logos Global Management LP has about 79.2% of it's holdings in Healthcare sector.
Sector | % |
---|---|
Healthcare | 79.2 |
Others | 20.8 |
Logos Global Management LP has about 2.1% of it's portfolio invested in the large-cap and mega-cap stocks.
Category | % |
---|---|
MID-CAP | 43.7 |
SMALL-CAP | 27.1 |
UNALLOCATED | 20.8 |
MICRO-CAP | 5.1 |
LARGE-CAP | 2.1 |
NANO-CAP | 1.2 |
About 65.8% of the stocks held by Logos Global Management LP either belong to S&P 500 or RUSSELL 2000 index.
Index | % |
---|---|
RUSSELL 2000 | 65.8 |
Others | 34.2 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
Logos Global Management LP has 53 stocks in it's portfolio. About 46.6% of the portfolio is in top 10 stocks. MRUS proved to be the most loss making stock for the portfolio. OCUL was the most profitable stock for Logos Global Management LP last quarter.
Last Reported on: 14 Nov, 2024Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
---|---|---|---|---|---|---|---|---|
ADVM | adverum biotechnologies inc | 0.32 | 416,666 | 2,925,000 | reduced | -50.00 | ||
AGLE | spyre therapeutics inc | 0.64 | 200,000 | 5,882,000 | reduced | -82.61 | ||
AKRO | akero therapeutics inc | 2.48 | 800,000 | 22,952,000 | reduced | -50.00 | ||
ALLK | allakos inc | 0.20 | 2,900,000 | 1,894,280 | reduced | -50.00 | ||
ANNX | annexon inc | 1.66 | 2,600,000 | 15,392,000 | reduced | -60.61 | ||
APLT | applied therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
ARVN | arvinas inc | 1.06 | 400,000 | 9,852,000 | new | |||
ATXS | astria therapeutics inc | 0.59 | 500,000 | 5,505,000 | reduced | -50.00 | ||
AVTX | avalo therapeutics inc | 0.55 | 539,079 | 5,121,250 | unchanged | 0.00 | ||
BCYC | bicycle therapeutics plc | 1.22 | 500,000 | 11,315,000 | new | |||
BEAM | beam therapeutics inc | 1.32 | 500,000 | 12,250,000 | new | |||
CLDX | celldex therapeutics inc new | 3.30 | 900,000 | 30,591,000 | new | |||
CMPS | compass pathways plc | 0.79 | 1,159,030 | 7,301,890 | reduced | -50.00 | ||
COGT | cogent biosciences inc | 2.33 | 2,000,000 | 21,600,000 | new | |||
CYBN | cybin inc | 0.58 | 600,000 | 5,334,000 | new | |||
CYBN | cybin inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
CYTK | cytokinetics inc | 2.28 | 400,000 | 21,120,000 | new | |||
DSGN | design therapeutics inc | 2.45 | 4,217,630 | 22,690,800 | reduced | -58.1 | ||
DYN | dyne therapeutics inc | 0.62 | 160,000 | 5,747,200 | reduced | -69.81 | ||
ELEV | elevation oncology inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||